1887

Chapter 28 : Diagnostic Approaches to Genitourinary Tract Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Diagnostic Approaches to Genitourinary Tract Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819071/9781555819088.ch28-1.gif /docserver/preview/fulltext/10.1128/9781555819071/9781555819088.ch28-2.gif

Abstract:

The accurate diagnosis of urethral and cervico-vaginal infections can be complex, requiring multiple, sophisticated laboratory tests, without which the causative organism may remain unknown. Failure to diagnose and cure people with urethral and vaginal infections is associated with patient morbidity and mortality and can facilitate the continued transmission of infections to partners and from mother to infant during birth (1).

Citation: Bristow C, Klausner J. 2016. Diagnostic Approaches to Genitourinary Tract Infections, p 386-400. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch28
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555819071.ch28
1. Holmes KK. 2008. Sexually Transmitted Diseases, 4th ed. McGraw-Hill Medical, New York, NY.
2. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M. 2009. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9:118129[CrossRef].[PubMed]
3. Brotman RM, Klebanoff MA, Nansel TR, Yu KF, Andrews WW, Zhang J, Schwebke JR. 2010. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 202:19071915[CrossRef].[PubMed]
4. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. 2003. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 37:319325[CrossRef].[PubMed]
5. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. 2003. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 36:663668[CrossRef].[PubMed]
6. Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA. 2012. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 9:e1001251[CrossRef].[PubMed]
7. WHO. 2004. Guidelines for the Management of Sexually Transmitted Infections. http://www.who.int/hiv/pub/sti/pub6/en/.
8. Clark JL, Lescano AG, Konda KA, Leon SR, Jones FR, Klausner JD, Coates TJ, Caceres CF, NIMH International Collaborative HIV/STD Prevention Trial. 2009. Syndromic management and STI control in urban Peru. PLoS One 4:e7201[CrossRef].[PubMed]
9. Klausner JD,. 2005. AIDS and sexually transmitted disease prevention and control. In Mayer KH, Pizer HF (ed), The AIDS Pandemic: Impact on Science and Society. Elsevier Academic Press, San Diego, CA.[CrossRef]
10. Geelen TH, Rossen JW, Beerens AM, Poort L, Morré SA, Ritmeester WS, van Kruchten HE, van de Pas MM, Savelkoul PH. 2013. Performance of cobas® 4800 and m2000 real-time™ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal and self-collected vaginal specimen. Diagn Microbiol Infect Dis 77:101105[CrossRef].[PubMed]
11. Moncada J, Schachter J, Liska S, Shayevich C, Klausner JD. 2009. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J Clin Microbiol 47:16571662[CrossRef].[PubMed]
12. Taylor D, Lunny C, Wong T, Gilbert M, Li N, Lester R, Krajden M, Hoang L, Ogilvie G. 2013. Self-collected versus clinician-collected sampling for sexually transmitted infections: a systematic review and meta-analysis protocol. Syst Rev 2:93[CrossRef].[PubMed]
13. Moss NJ, Ahrens K, Kent CK, Klausner JD. 2006. The decline in clinical sequelae of genital Chlamydia trachomatis infection supports current control strategies. J Infect Dis 193:13361338, author reply 1338–1339[CrossRef].[PubMed]
14. CDC. 2014. Self-Study STD Modules for Clinicians: Vaginitis. http://www2a.cdc.gov/stdtraining/self-study/vaginitis/default.htm.
15. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). 2010. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 59(RR-12):1110.[PubMed]
16. Johnston VJ, Mabey DC. 2008. Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis 21:5664[CrossRef].[PubMed]
17. Allsworth JE, Ratner JA, Peipert JF. 2009. Trichomoniasis and other sexually transmitted infections: results from the 2001–2004 National Health and Nutrition Examination Surveys. Sex Transm Dis 36:738744[CrossRef].[PubMed]
18. Poole DN, McClelland RS. 2013. Global epidemiology of Trichomonas vaginalis. Sex Transm Infect 89:418422[CrossRef].[PubMed]
19. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. 2007. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin Infect Dis 45:13191326[CrossRef].[PubMed]
20. Kissinger P, Adamski A. 2013. Trichomoniasis and HIV interactions: a review. Sex Transm Infect 89:426433[CrossRef].[PubMed]
21. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M, Heyward WL, Ryder RW, Piot P. 1993. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95102[CrossRef].[PubMed]
22. McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM. 2007. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 195:698702[CrossRef].[PubMed]
23. Cotch MF, Pastorek JG II, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG, The Vaginal Infections and Prematurity Study Group. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 24:353360[CrossRef].[PubMed]
24. Paisarntantiwong R, Brockmann S, Clarke L, Landesman S, Feldman J, Minkoff H. 1995. The relationship of vaginal trichomoniasis and pelvic inflammatory disease among women colonized with Chlamydia trachomatis. Sex Transm Dis 22:344347[CrossRef].[PubMed]
25. Hobbs MM, Seña AC. 2013. Modern diagnosis of Trichomonas vaginalis infection. Sex Transm Infect 89:434438[CrossRef].[PubMed]
26. Nye MB, Schwebke JR, Body BA. 2009. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol 200:188.e1188.e7[CrossRef].[PubMed]
27. Patil MJ, Nagamoti JM, Metgud SC. 2012. Diagnosis of Trichomonas vaginalis from vaginal specimens by wet mount microscopy, in pouch TV culture system, and PCR. J Glob Infect Dis 4:2225[CrossRef].[PubMed]
28. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. 2002. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 35:576580[CrossRef].[PubMed]
29. Cartwright CP, Lembke BD, Ramachandran K, Body BA, Nye MB, Rivers CA, Schwebke JR. 2013. Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women. J Clin Microbiol 51:36943699[CrossRef].[PubMed]
30. Andrea SB, Chapin KC. 2011. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications. J Clin Microbiol 49:866869[CrossRef].[PubMed]
31. Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Miller WC, Hobbs MM. 2007. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 45:194198[CrossRef].[PubMed]
32. Schwebke JR, Hobbs MM, Taylor SN, Sena AC, Catania MG, Weinbaum BS, Johnson AD, Getman DK, Gaydos CA. 2011. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol 49:41064111[CrossRef].[PubMed]
33. Bandea CI, Joseph K, Secor EW, Jones LA, Igietseme JU, Sautter RL, Hammerschlag MR, Fajman NN, Girardet RG, Black CM. 2013. Development of PCR assays for detection of Trichomonas vaginalis in urine specimens. J Clin Microbiol 51:12981300[CrossRef].[PubMed]
34. Gaydos CA, Barnes MR, Quinn N, Jett-Goheen M, Hsieh YH. 2013. Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment. Sex Transm Infect 89:504508[CrossRef].[PubMed]
35. Gaydos CA, Hsieh YH, Barnes M, Quinn N, Agreda P, Jett-Goheen M, Whittle P, Hogan T. 2011. Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex Transm Dis 38:828832[CrossRef].[PubMed]
36. Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. 2014. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 59:834841[CrossRef].[PubMed]
37. Sobel JD. 2007. Vulvovaginal candidosis. Lancet 369:19611971[CrossRef].[PubMed]
38. Odds FC, Webster CE, Mayuranathan P, Simmons PD. 1988. Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J Med Vet Mycol 26:277283[CrossRef].[PubMed]
39. Sobel JD. 1985. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 152:924935[CrossRef].[PubMed]
40. Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. 2002. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol 187:569574[CrossRef].[PubMed]
41. Eckert LO. 2006. Clinical practice. Acute vulvovaginitis. N Engl J Med 355:12441252[CrossRef].[PubMed]
42. Moreira D, Paula CR. 2006. Vulvovaginal candidiasis. Int J Gynaecol Obstet 92:266267[CrossRef].[PubMed]
43. Sobel JD, Hay P. 2010. Diagnostic techniques for bacterial vaginosis and vulvovaginal candidiasis—requirement for a simple differential test. Expert Opin Med Diagn 4:333341[CrossRef].[PubMed]
44. Petrikkos G, Makrilakis K, Pappas S. 2007. Affirm VP III in the detection and identification of Candida species in vaginitis. Int J Gynaecol Obstet 96:3940[CrossRef].[PubMed]
45. Trama JP, Adelson ME, Raphaelli I, Stemmer SM, Mordechai E. 2005. Detection of Candida species in vaginal samples in a clinical laboratory setting. Infect Dis Obstet Gynecol 13:6367[CrossRef].[PubMed]
46. Trama JP, Mordechai E, Adelson ME. 2005. Detection and identification of Candida species associated with Candida vaginitis by real-time PCR and pyrosequencing. Mol Cell Probes 19:145152[CrossRef].[PubMed]
47. Keshavarz H, Duffy SW, Sadeghi-Hassanabadi A, Zolghadr Z, Oboodi B. 2001. Risk factors for and relationship between bacterial vaginosis and cervicitis in a high risk population for cervicitis in Southern Iran. Eur J Epidemiol 17:8995[CrossRef].[PubMed]
48. Marrazzo JM. 2005. Mucopurulent cervicitis: no longer ignored, but still misunderstood. Infect Dis Clin North Am 19:333349, viii[CrossRef]. viii.[PubMed]
49. Marrazzo JM, Wiesenfeld HC, Murray PJ, Busse B, Meyn L, Krohn M, Hillier SL. 2006. Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 193:617624[CrossRef].[PubMed]
50. Peipert JF, Montagno AB, Cooper AS, Sung CJ. 1997. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 177:11841187[CrossRef].[PubMed]
51. Schwebke JR, Schulien MB, Zajackowski M. 1995. Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis. Infect Dis Obstet Gynecol 3:119122[CrossRef].[PubMed]
52. Schwebke JR, Weiss HL. 2002. Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis 29:5964[CrossRef].[PubMed]
53. Kenyon C, Colebunders R, Crucitti T. 2013. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 209:505523[CrossRef].[PubMed]
54. Klausner JD, Hook EW III (ed). 2007. Current Diagnosis & Treatment of Sexually Transmitted Diseases. McGraw-Hill, New York, NY.
55. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. 2008. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22:14931501[CrossRef].[PubMed]
56. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J. 1999. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180:18631868[CrossRef].[PubMed]
57. Gondo F, da Silva MG, Polettini J, Tristao AR, Peracoli JC, Witkin SS, Rudge MV. 2011. Vaginal flora alterations and clinical symptoms in low-risk pregnant women. Gynecol Obstet Invest 71:158162[CrossRef].[PubMed]
58. Hay PE. 2004. Bacterial vaginosis and miscarriage. Curr Opin Infect Dis 17:4144[CrossRef].[PubMed]
59. Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, Romero R. 2011. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 118:533549[CrossRef].[PubMed]
60. Menon R, Dunlop AL, Kramer MR, Fortunato SJ, Hogue CJ. 2011. An overview of racial disparities in preterm birth rates: caused by infection or inflammatory response? Acta Obstet Gynecol Scand 90:13251331[CrossRef].[PubMed]
61. Fredricks DN, Fiedler TL, Marrazzo JM. 2005. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353:18991911[CrossRef].[PubMed]
62. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297301.[PubMed]
63. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. 1983. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74:1422[CrossRef].[PubMed]
64. Bradshaw CS, Morton AN, Garland SM, Horvath LB, Kuzevska I, Fairley CK. 2005. Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol 43:13041308[CrossRef].[PubMed]
65. Madhivanan P, Krupp K, Li T, Ravi K, Selezneva J, Srinivas V, Arun A, Klausner JD. 2014. Performance of BVBlue rapid test in detecting bacterial vaginosis among women in Mysore, India. Infect Dis Obstet Gynecol 2014:908313[CrossRef].[PubMed]
66. Myziuk L, Romanowski B, Johnson SC. 2003. BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol 41:19251928[CrossRef].[PubMed]
67. Sumeksri P, Koprasert C, Panichkul S. 2005. BVBLUE test for diagnosis of bacterial vaginosis in pregnant women attending antenatal care at Phramongkutklao Hospital. J Med Assoc Thai 88(Suppl 3):S7S13.[PubMed]
68. Dunkelberg WE Jr. 1965. Diagnosis of Hemophilus vaginalis vaginitis by Gram-stained smears. Am J Obstet Gynecol 91:9981000.[PubMed]
69. Spiegel CA, Amsel R, Holmes KK. 1983. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol 18:170177.[PubMed]
70. Brown HL, Fuller DD, Jasper LT, Davis TE, Wright JD. 2004. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect Dis Obstet Gynecol 12:1721[CrossRef].[PubMed]
71. Africa CW. 2013. Efficacy of methods used for the diagnosis of bacterial vaginosis. Expert Opin Med Diagn 7:189200[CrossRef].[PubMed]
72. Forney LJ, Zhou X, Brown CJ. 2004. Molecular microbial ecology: land of the one-eyed king. Curr Opin Microbiol 7:210220[CrossRef].[PubMed]
73. Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G, Donders GG, Brigidi P. 2007. Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol 73:57315741[CrossRef].[PubMed]
74. Cartwright CP, Lembke BD, Ramachandran K, Body BA, Nye MB, Rivers CA, Schwebke JR. 2012. Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis. J Clin Microbiol 50:23212329[CrossRef].[PubMed]
75. Lusk MJ, Konecny P. 2008. Cervicitis: a review. Curr Opin Infect Dis 21:4955.[PubMed]
76. Brunham RC, Paavonen J, Stevens CE, Kiviat N, Kuo CC, Critchlow CW, Holmes KK. 1984. Mucopurulent cervicitis—the ignored counterpart in women of urethritis in men. N Engl J Med 311:16[CrossRef].[PubMed]
77. Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC. 2009. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 36:598606[CrossRef].[PubMed]
78. Korte JE, Baseman JB, Cagle MP, Herrera C, Piper JM, Holden AE, Perdue ST, Champion JD, Shain RN. 2006. Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. Am J Reprod Immunol 55:265275[CrossRef].[PubMed]
79. Taylor SN. 2014. Cervicitis of unknown etiology. Curr Infect Dis Rep 16:409[CrossRef].[PubMed]
80. Coleman JS, Hitti J, Bukusi EA, Mwachari C, Muliro A, Nguti R, Gausman R, Jensen S, Patton D, Lockhart D, Coombs R, Cohen CR. 2007. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 21:755759[CrossRef].[PubMed]
81. Corey L, Wald A, Celum CL, Quinn TC. 2004. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 35:435445[CrossRef].[PubMed]
82. Kreiss J, Willerford DM, Hensel M, Emonyi W, Plummer F, Ndinya-Achola J, Roberts PL, Hoskyn J, Hillier S, Kiviat N, Holmes KK. 1994. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 170:15971601[CrossRef].[PubMed]
83. Mcclelland RS, Wang CC, Mandaliya K, Overbaugh J, Reiner MT, Panteleeff DD, Lavreys L, Ndinya-Achola J, Bwayo JJ, Kreiss JK. 2001. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 15:105110[CrossRef].[PubMed]
84. Marrazzo JM, Handsfield HH, Whittington WL. 2002. Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstet Gynecol 100:579584[CrossRef].[PubMed]
85. Nyirjesy P. 2001. Nongonococcal and nonchlamydial cervicitis. Curr Infect Dis Rep 3:540545[CrossRef].[PubMed]
86. Marrazzo JM, Martin DH. 2007. Management of women with cervicitis. Clin Infect Dis 44(Suppl 3):S102S110[CrossRef].[PubMed]
87. WHO. 2012. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections—2008. http://www.who.int/reproductivehealth/publications/rtis/stisestimates/en/.
88. Centers for Disease Control and Prevention. 2013. Sexually Transmitted Disease Surveillance 2012. US Department of Health and Human Services, Atlanta, GA. http://www.cdc.gov/std/stats12/Surv2012.pdf.
89. Frommell GT, Rothenberg R, Wang S, McIntosh K, Wintersgill C, Allaman J, Orr I. 1979. Chlamydial infection of mothers and their infants. J Pediatr 95:2832[CrossRef].[PubMed]
90. Holmes KK, Counts GW, Beaty HN. 1971. Disseminated gonococcal infection. Ann Intern Med 74:979993[CrossRef].[PubMed]
91. Reighard SD, Sweet RL, Vicetti Miguel C, Vicetti Miguel RD, Chivukula M, Krishnamurti U, Cherpes TL. 2011. Endometrial leukocyte subpopulations associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis genital tract infection. Am J Obstet Gynecol 205:324.e1324.e7[CrossRef].[PubMed]
92. Peipert JF. 2003. Clinical practice. Genital chlamydial infections. N Engl J Med 349:24242430[CrossRef].[PubMed]
93. Buimer M, van Doornum GJ, Ching S, Peerbooms PG, Plier PK, Ram D, Lee HH. 1996. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening. J Clin Microbiol 34:23952400.[PubMed]
94. Jaschek G, Gaydos CA, Welsh LE, Quinn TC. 1993. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol 31:12091212.[PubMed]
95. Gaydos CA. 2014. Review of use of a new rapid real-time PCR, the Cepheid GeneXpert® (Xpert) CT/NG assay, for Chlamydia trachomatis and Neisseria gonorrhoeae: results for patients while in a clinical setting. Expert Rev Mol Diagn 14:135137[CrossRef].[PubMed]
96. Gaydos CA, Van Der Pol B, Jett-Goheen M, Barnes M, Quinn N, Clark C, Daniel GE, Dixon PB, Hook EW III, CT/NG Study Group. 2013. Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 51:16661672[CrossRef].[PubMed]
97. Chernesky M, Jang D, Gilchrist J, Hatchette T, Poirier A, Flandin JF, Smieja M, Ratnam S. 2014. Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs. J Clin Microbiol 52:23052310[CrossRef].[PubMed]
98. Crucitti T, De Deken B, Smet H, Cuylaerts V, Abdellati S, Vuylsteke B. 2013. Evaluation of the APTIMA Combo 2 Assay using self-administered vaginal swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. Diagn Microbiol Infect Dis 76:385386[CrossRef].[PubMed]
99. Mushanski LM, Brandt K, Coffin N, Levett PN, Horsman GB, Rank EL. 2012. Comparison of the BD Viper System with XTR Technology to the Gen-Probe APTIMA COMBO 2 Assay using the TIGRIS DTS system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens. Sex Transm Dis 39:514517[CrossRef].[PubMed]
100. Pabbaraju K, Wong S, Song JJ, Singh AE, Read R, Drews SJ. 2013. Utility of specimens positive for Neisseria gonorrhoeae by the Aptima Combo 2 assay for assessment of strain diversity and antibiotic resistance. J Clin Microbiol 51:41564160[CrossRef].[PubMed]
101. Taylor SN, Liesenfeld O, Lillis RA, Body BA, Nye M, Williams J, Eisenhut C, Hook EW III, Van Der Pol B. 2012. Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Sex Transm Dis 39:543549[CrossRef].[PubMed]
102. Van Der Pol B, Liesenfeld O, Williams JA, Taylor SN, Lillis RA, Body BA, Nye M, Eisenhut C, Hook EW III. 2012. Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 50:22442249[CrossRef].[PubMed]
103. Van Der Pol B, Taylor SN, Lebar W, Davis T, Fuller D, Mena L, Fine P, Gaydos CA, Martin DH, Hook EW III. 2012. Clinical evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper™ system with XTR™ technology. Sex Transm Dis 39:147153[CrossRef].[PubMed]
104. Dize L, West S, Williams JA, Van Der Pol B, Quinn TC, Gaydos CA. 2013. Comparison of the Abbott m2000 RealTime CT assay and the Cepheid GeneXpert CT/NG assay to the Roche Amplicor CT assay for detection of Chlamydia trachomatis in ocular samples from Tanzania. J Clin Microbiol 51:16111613[CrossRef].[PubMed]
105. Goldenberg SD, Finn J, Sedudzi E, White JA, Tong CY. 2012. Performance of the GeneXpert CT/NG assay compared to that of the Aptima AC2 assay for detection of rectal Chlamydia trachomatis and Neisseria gonorrhoeae by use of residual Aptima Samples. J Clin Microbiol 50:38673869[CrossRef].[PubMed]
106. Cheng A, Qian Q, Kirby JE. 2011. Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay. J Clin Microbiol 49:12941300[CrossRef].[PubMed]
107. Han Y, Yin YP, Shi MQ, Zheng BJ, Zhong MY, Jiang N, Chen SC, Chen XS. 2014. Evaluation of Abbott RealTime CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical swabs from female sex workers in China. PLoS One 9:e89658[CrossRef].[PubMed]
108. Tabrizi SN, Unemo M, Limnios AE, Hogan TR, Hjelmevoll SO, Garland SM, Tapsall J. 2011. Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. J Clin Microbiol 49:36103615[CrossRef].[PubMed]
109. Black CM, Morse SA. 2000. The use of molecular techniques for the diagnosis and epidemiologic study of sexually transmitted infections. Curr Infect Dis Rep 2:3143[CrossRef].[PubMed]
110. Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, Steece R, Markowitz LE, Devine OJ, Walsh CM, Wang S, Gunter DC, Irwin KL, DeLisle S, Berman SM. 2002. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections—2002. MMWR Recomm Rep 51:138; quiz CE31–CE34.
111. Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero DV, Schachter J. 2003. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 41:304309[CrossRef].[PubMed]
112. Renault CA, Hall C, Kent CK, Klausner JD. 2006. Use of NAATs for STD diagnosis of GC and CT in non-FDA-cleared anatomic specimens. Med Lab Observ 38:10, 1216, 21–2; quiz 24, 27.
113. Page-Shafer K, Graves A, Kent C, Balls JE, Zapitz VM, Klausner JD. 2002. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis 34:173176[CrossRef].[PubMed]
114. Yuan Y, Zhang YX, Watkins NG, Caldwell HD. 1989. Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun 57:10401049.[PubMed]
115. Little MC, Andrews J, Moore R, Bustos S, Jones L, Embres C, Durmowicz G, Harris J, Berger D, Yanson K, Rostkowski C, Yursis D, Price J, Fort T, Walters A, Collis M, Llorin O, Wood J, Failing F, O'Keefe C, Scrivens B, Pope B, Hansen T, Marino K, Williams K, Boenisch M. 1999. Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin Chem 45:777784.[PubMed]
116. Walker GT, Fraiser MS, Schram JL, Little MC, Nadeau JG, Malinowski DP. 1992. Strand displacement amplification—an isothermal, in vitro DNA amplification technique. Nucleic Acids Res 20:16911696[CrossRef].[PubMed]
117. Barry PM, Klausner JD. 2009. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother 10:555577[CrossRef].[PubMed]
118. Buono S, Wu A, Hess DC, Carlson JS, Rauch L, Philip SS, Barry P, Bernstein K, Klausner JD, Pandori MW. 2012. Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California. Microb Drug Resist 18:510517[CrossRef].[PubMed]
119. Pandori M, Barry PM, Wu A, Ren A, Whittington WL, Liska S, Klausner JD. 2009. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother 53:40324034[CrossRef].[PubMed]
120. Siedner MJ, Pandori M, Castro L, Barry P, Whittington WL, Liska S, Klausner JD. 2007. Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. J Clin Microbiol 45:12501254[CrossRef].[PubMed]
121. Daley G, Russell D, Tabrizi S, McBride J. 2014. Mycoplasma genitalium: a review. Int J STD AIDS 25:475487[CrossRef].[PubMed]
122. Falk L, Fredlund H, Jensen JS. 2005. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 81:7378[CrossRef].[PubMed]
123. Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, Totten PA. 2003. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 187:650657[CrossRef].[PubMed]
124. Ross JD, Jensen JS. 2006. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 82:269271[CrossRef].[PubMed]
125. Schlicht MJ, Lovrich SD, Sartin JS, Karpinsky P, Callister SM, Agger WA. 2004. High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin. J Clin Microbiol 42:46364640[CrossRef].[PubMed]
126. Taylor-Robinson D. 2002. Mycoplasma genitalium—an up-date. Int J STD AIDS 13:145151[CrossRef].[PubMed]
127. Anagrius C, Loré B, Jensen JS. 2005. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 81:458462[CrossRef].[PubMed]
128. Thurman AR, Musatovova O, Perdue S, Shain RN, Baseman JG, Baseman JB. 2010. Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads. Int J STD AIDS 21:177183[CrossRef].[PubMed]
129. Taylor-Robinson D. 2007. The role of mycoplasmas in pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 21:425438[CrossRef].[PubMed]
130. Bjartling C, Osser S, Persson K. 2010. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 117:361364[CrossRef].[PubMed]
131. Haggerty CL, Totten PA, Astete SG, Lee S, Hoferka SL, Kelsey SF, Ness RB. 2008. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 84:338342[CrossRef].[PubMed]
132. Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK, Sinei SK, Bwayo JJ, Totten PA. 2002. Association between Mycoplasma genitalium and acute endometritis. Lancet 359:765766[CrossRef].[PubMed]
133. Jensen JS. 2004. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol 18:111[CrossRef].[PubMed]
134. Manhart LE, Broad JM, Golden MR. 2011. Mycoplasma genitalium: should we treat and how? Clin Infect Dis 53(Suppl 3):S129S142[CrossRef].[PubMed]
135. Taylor-Robinson D, Jensen JS. 2011. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev 24:498514[CrossRef].[PubMed]
136. Weinstein SA, Stiles BG. 2011. A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium. Sex Health 8:143158[CrossRef].[PubMed]
137. Horner PJ, Taylor-Robinson D. 2011. Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis. Sex Transm Infect 87:3840[CrossRef].[PubMed]
138. Krieger JN, Riley DE. 2004. Chronic prostatitis: charlottesville to Seattle. J Urol 172:25572560[CrossRef].[PubMed]
139. Bradshaw CS, Tabrizi SN, Read TR, Garland SM, Hopkins CA, Moss LM, Fairley CK. 2006. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 193:336345[CrossRef].[PubMed]
140. Svenstrup HF, Fedder J, Kristoffersen SE, Trolle B, Birkelund S, Christiansen G. 2008. Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility—a prospective study. Fertil Steril 90:513520[CrossRef].[PubMed]
141. Hitti J, Garcia P, Totten P, Paul K, Astete S, Holmes KK. 2010. Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women. Sex Transm Dis 37:8185[CrossRef].[PubMed]
142. Oakeshott P, Hay P, Taylor-Robinson D, Hay S, Dohn B, Kerry S, Jensen JS. 2004. Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome. BJOG 111:14641467[CrossRef].[PubMed]
143. Haggerty CL, Totten PA, Astete SG, Ness RB. 2006. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006:30184[CrossRef].[PubMed]
144. Hamasuna R. 2013. Mycoplasma genitalium in male urethritis: diagnosis and treatment in Japan. Int J Urol 20:676684[CrossRef].[PubMed]
145. Andrés E, Martínez N, Planas A. 2011. Expression and characterization of a Mycoplasma genitalium glycosyltransferase in membrane glycolipid biosynthesis: potential target against mycoplasma infections. J Biol Chem 286:3536735379[CrossRef].[PubMed]
146. Weinstein SA, Stiles BG. 2012. Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium. Expert Rev Anti Infect Ther 10:487499[CrossRef].[PubMed]
147. Pond MJ, Nori AV, Witney AA, Lopeman RC, Butcher PD, Sadiq ST. 2014. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 58:631637[CrossRef].[PubMed]
148. Low N, Broutet N, Adu-Sarkodie Y, Barton P, Hossain M, Hawkes S. 2006. Global control of sexually transmitted infections. Lancet 368:20012016[CrossRef].[PubMed]
149. Sanchez J, Lama JR, Peinado J, Paredes A, Lucchetti A, Russell K, Kochel T, Sebastian JL. 2009. High HIV and ulcerative sexually transmitted infection incidence estimates among men who have sex with men in Peru: awaiting for an effective preventive intervention. J Acquir Immune Defic Syndr 51(Suppl 1):S47S51[CrossRef].[PubMed]
150. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. 2006. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:7383[CrossRef].[PubMed]
151. Mertz KJ, Trees D, Levine WC, Lewis JS, Litchfield B, Pettus KS, Morse SA, St Louis ME, Weiss JB, Schwebke J, Dickes J, Kee R, Reynolds J, Hutcheson D, Green D, Dyer I, Richwald GA, Novotny J, Weisfuse I, Goldberg M, O'Donnell JA, Knaup R, The Genital Ulcer Disease Surveillance Group. 1998. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. J Infect Dis 178:17951798[CrossRef].[PubMed]
152. Mertz KJ, Weiss JB, Webb RM, Levine WC, Lewis JS, Orle KA, Totten PA, Overbaugh J, Morse SA, Currier MM, Fishbein M, St Louis ME. 1998. An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis 178:10601066[CrossRef].[PubMed]
153. Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, Klausner JD. 2004. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 18:20752079[CrossRef].[PubMed]
154. Kofoed K, Gerstoft J, Mathiesen LR, Benfield T. 2006. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis 33:143148[CrossRef].[PubMed]
155. Mackay IM, Harnett G, Jeoffreys N, Bastian I, Sriprakash KS, Siebert D, Sloots TP. 2006. Detection and discrimination of herpes simplex viruses, Haemophilus ducreyi, Treponema pallidum, and Calymmatobacterium (Klebsiella) granulomatis from genital ulcers. Clin Infect Dis 42:14311438[CrossRef].[PubMed]
156. Orle KA, Gates CA, Martin DH, Body BA, Weiss JB. 1996. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol 34:4954.[PubMed]
157. Scott LJ, Gunson RN, Carman WF, Winter AJ. 2010. A new multiplex real-time PCR test for HSV1/2 and syphilis: an evaluation of its impact in the laboratory and clinical setting. Sex Transm Infect 86:537539[CrossRef].[PubMed]
158. Suntoke TR, Hardick A, Tobian AA, Mpoza B, Laeyendecker O, Serwadda D, Opendi P, Gaydos CA, Gray RH, Wawer MJ, Quinn TC, Reynolds SJ. 2009. Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex Transm Infect 85:97101[CrossRef].[PubMed]
159. Ho EL, Lukehart SA. 2011. Syphilis: using modern approaches to understand an old disease. J Clin Invest 121:45844592[CrossRef].[PubMed]
160. Zetola NM, Klausner JD. 2007. Syphilis and HIV infection: an update. Clin Infect Dis 44:12221228[CrossRef].[PubMed]
161. Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. 2013. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 91:217226[CrossRef].[PubMed]
162. De Santis M, De Luca C, Mappa I, Spagnuolo T, Licameli A, Straface G, Scambia G. 2012. Syphilis Infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol 2012:430585[CrossRef].[PubMed]
163. Mwapasa V, Rogerson SJ, Kwiek JJ, Wilson PE, Milner D, Molyneux ME, Kamwendo DD, Tadesse E, Chaluluka E, Meshnick SR. 2006. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS 20:18691877[CrossRef].[PubMed]